| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 02/01/2005 | US6849629 Heteroaromatic substituted sulfonyl or sulfoxide or thio-pyridazinone derivatives, useful for treating diabetic complications and cardiovascular disorders |
| 02/01/2005 | US6849626 Aza-amino acid derivatives (factor Xa inhibitors 15) |
| 02/01/2005 | US6849617 Administering Tissue factor pathway inhibitors for prophylaxis of thrombosis and cardiovascular disorders; anticoagulants |
| 02/01/2005 | US6849436 Nucleotide sequences coding polypeptide for use in the treatment of blood disorders, gout, kidney stones, Lesch-Nyhan syndrome, renal failure and uricaciduria |
| 02/01/2005 | CA2166326C Pyridazinone derivatives |
| 02/01/2005 | CA2094261C Polypeptide of a growth factor receptor family, application in the diagnosis and treatment of myeloproliferative diseases |
| 01/27/2005 | WO2005007651A1 2-acylaminothiazole derivative or salt thereof |
| 01/27/2005 | WO2005007644A1 Heteroaryloxy nitrogenous saturated heterocyclic derivative |
| 01/27/2005 | WO2005007183A2 Treatment of anemia |
| 01/27/2005 | WO2004091613A3 Substituted phenyl acetamides and their use as protease inhibitors |
| 01/27/2005 | WO2003076565A3 Methods of using 46828, a human acyl-coa synthetase |
| 01/27/2005 | US20050020657 Compositions and methods involving the combination of a thromboxane A2 receptor antagonist and an inhibitor of cyclooxygenase-2 |
| 01/27/2005 | US20050020621 Prevent reduced blood flow to brain |
| 01/27/2005 | US20050020614 Stabilization plaque in blood vessels; therapy for restenosis in diabetic patients |
| 01/27/2005 | US20050020584 Benzamide derivatives as antagonists of orexin receptors |
| 01/27/2005 | US20050020562 Drugs; analgesics; anesthetics; antiarrhythmia agents; antiinflammatory agents ; incontinence; gastrointestinal disorders; neurodegenerative disease |
| 01/27/2005 | US20050020540 Biphenylcarboxylic amide derivatives as p38-kinase inhibitors |
| 01/27/2005 | US20050020504 C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases |
| 01/27/2005 | US20050020500 Glycosaminoglycan-polypeptide complex; antiarthritic agents |
| 01/27/2005 | US20050020487 Therapy for anemia |
| 01/27/2005 | US20050019908 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 01/27/2005 | US20050019378 Transdermal drug delivery system of strychnine, brucine, securinine and their salts |
| 01/27/2005 | CA2529790A1 Heteroaryloxy nitrogenous saturated heterocyclic derivative |
| 01/26/2005 | EP1499746A1 Method to inhibit cell growth using oligonucleotides |
| 01/26/2005 | EP1499736A1 Improved chimeric glycoproteins and pseudotyped lentiviral vectors |
| 01/26/2005 | EP1499719A1 FACTOR VII OR VIIa POLYPEPTIDE VARIANTS |
| 01/26/2005 | EP1499619A1 Bicyclic heterocycles, medicaments containing these compounds, their use, and method for the production thereof |
| 01/26/2005 | EP1499600A1 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors |
| 01/26/2005 | EP1499599A1 Substituted pyrazine derivatives |
| 01/26/2005 | EP1499591A1 Carboxylic acid amides |
| 01/26/2005 | EP1499588A1 Melanocortin receptor ligands |
| 01/26/2005 | EP1499352A1 Recombinant anti-interleukin-9 antibodies |
| 01/26/2005 | EP1499345A2 Protein a compositions and methods of use |
| 01/26/2005 | EP1499336A2 Protease inhibitors |
| 01/26/2005 | EP1499328A1 Methods of treating necrotizing enterocolitis |
| 01/26/2005 | EP1499314A1 N-acyl piperidine derivatives for use as melanocortin receptor ligands in the treatment of feeding disorders |
| 01/26/2005 | EP1499305A2 Use of ep4 receptor ligands in the treatment of il-6 involved diseases |
| 01/26/2005 | EP1499298A1 Oral administration form for difficulty soluble basic active ingredients which are applied orally |
| 01/26/2005 | EP1499297A2 Pharmaceutical formulation comprising atorvastatin calcium |
| 01/26/2005 | EP1499186A1 Use of heme oxygenase-1 and products of heme degradation |
| 01/26/2005 | EP1430140A4 Isoform-selective inhibitors and activators of pde3 cyclic |
| 01/26/2005 | EP1427727B1 Compounds which inhibit the release of inflammatory cytokines |
| 01/26/2005 | EP1278749B1 USE OF 5-THIO-, SULFINYL- AND SULFONYLPYRAZOLO 3,4-b]-PYRIDINES AS CYCLIN DEPENDENT KINASE INHIBITORS |
| 01/26/2005 | EP1082303B1 Heterocyclic derivatives which inhibit factor xa |
| 01/26/2005 | EP0983267B1 Amidoaromatic ring sulfonamide hydroxamic acid compounds |
| 01/26/2005 | EP0914110B1 Method of modulating microcirculation |
| 01/26/2005 | EP0886651B1 Persephin and related growth factors |
| 01/26/2005 | CN1571796A Melanocortin receptor ligands |
| 01/26/2005 | CN1571794A Cyclosporine analogue mixtures and their use as immunomodulating agents |
| 01/26/2005 | CN1571789A Himbacine analogues as thrombin receptor antagonists |
| 01/26/2005 | CN1569226A Freeze dried powder injection of hirudin and its preparation method |
| 01/26/2005 | CN1569121A Medicinal capsule of Chinese clinopodium herb for and its preparing process |
| 01/26/2005 | CN1569088A 'Heiguteng' exract, its pharmaceutical composition and its use |
| 01/26/2005 | CN1569054A Dripping pills of 'Xiao Chaihu' |
| 01/26/2005 | CN1569006A Usage of sulfonylureas derivant in the preparing process of blood vessel embolism disease treating medicine |
| 01/26/2005 | CN1568977A Sodium ozagrel for injection and its preparation |
| 01/26/2005 | CN1186344C Amino acid compounds and use thereof as NEP, ACE and ECE inhibitors |
| 01/26/2005 | CN1186318C Novel benzenesulphonamide compound, its prepn. process and medicinal compsns. contg. them |
| 01/26/2005 | CN1186096C Hemostatics powder and preparation thereof |
| 01/26/2005 | CN1186077C Medicine for stopping pain, diminishing inflammation, removing necrosis and promoting granulation |
| 01/26/2005 | CN1186062C Antiinflammatory hemostatic gynecologic medicine and use thereof |
| 01/26/2005 | CN1186038C Capsule for treating aplastic anemia and its production method |
| 01/25/2005 | US6846958 Synthesis of benzimidate from benzoic acid |
| 01/25/2005 | US6846827 Antiinflammatory agents; antiallergens; antiarthritic agents |
| 01/25/2005 | US6846676 In Vivo production and delivery of erythropoietin or insulinotropin for gene therapy |
| 01/25/2005 | US6846670 Expressing heterologous nucleotide sequences in cells; obtain vascular cells, incubate with herpes virus, monitor propagation of virus in central nervous system |
| 01/25/2005 | US6846499 Medical effect of jojoba oil |
| 01/25/2005 | CA2309352C Heterocyclic-substituted tricyclics as thrombin receptor antagonists |
| 01/25/2005 | CA2123224C Murine monoclonal antibody (5c8) recognizes a human glycoprotein on the surface of t-lymphocytes |
| 01/25/2005 | CA2089853C Polyethylene glycol-hirudine conjugates, process for their preparation, and their use in thrombosis therapy |
| 01/20/2005 | WO2005004862A2 Method for photodynamic inactivation of pathogens using ala |
| 01/20/2005 | WO2004101611A3 Peptides that bind to the erythropoietin receptor |
| 01/20/2005 | WO2004098627A9 Inhibition of platelet aggregation through acyclovir and two peptide antagonists |
| 01/20/2005 | WO2004064742A9 Methods and compositions for p2x receptor calcium entry channels and other calcium entry mechanisms |
| 01/20/2005 | WO2004038408A3 Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 14 (gpr14) |
| 01/20/2005 | WO2003066881A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 01/20/2005 | WO2003062392A3 Methods of treating conditions associated with an edg receptor |
| 01/20/2005 | US20050015820 Using transgenic mouse tissue as model for monitoring agents that affect appetite, energy expenditure and caloric and food intake; dietetics and weight gain |
| 01/20/2005 | US20050014787 5-amidino-2-hydroxybenzenesulfonamide derivatives medicinal compoistions containing the same medicinal use thereof and intermediates in the production thereof |
| 01/20/2005 | US20050014781 Ring fused pyrazole derivatives as CRF antagonists |
| 01/20/2005 | US20050014770 Use of dipyridamole or mopidamole for treatment and prevention of thromboembolic diseases and disorders caused by excessive formation of thrombin and/or by elevated expression of thrombin receptors |
| 01/20/2005 | US20050014757 Serotonin receptor antagonist; psychological disorders; side effect reduction |
| 01/20/2005 | US20050014705 E.g., dimethylcarbamic acid, 2-oxo-3-benzyl-4-methyl-2H-1-benzopyran; affects both the Tumor Necrosis Factor alpha level and transcription activity of NuclearFactor kappa Beta; antiimmunoinflammatory agents and autoimmune properties; antiarthritis agents; rheummatic diseases; osteoporosis; leukemia |
| 01/20/2005 | US20050014701 Synergistic mixture; anticoagulants |
| 01/20/2005 | US20050014699 Combinations of enzyme inhibitor-containing preparations and the use thereof |
| 01/20/2005 | US20050014695 Uses of a chemokine receptor able to bind to MCP-1, MIP-1 alpha and/or rantes |
| 01/20/2005 | US20050014686 Somatostatin analogues |
| 01/20/2005 | US20050014222 Phosphatases which activate map kinase pathways |
| 01/20/2005 | US20050014188 Isolated human dehydrogenases, nucleic acid molecules encoding these human dehydrogenases, and uses thereof |
| 01/20/2005 | US20050013866 Particulate vectors for improving oral absorption of active principles |
| 01/20/2005 | DE10329457A1 New 1,2-bis-phenylaminocarbonyl-pyrrolidine derivatives, useful for treating or preventing e.g. thrombosis, myocardial infarct and arteriosclerosis, are inhibitors of coagulation factor Xa |
| 01/20/2005 | CA2569537A1 Use of betaine for treating arteritis |
| 01/19/2005 | EP1498150A1 Delivery of solid drug compositions |
| 01/19/2005 | EP1498139A1 Novel thrombomodulin expression promoters |
| 01/19/2005 | EP1498131A1 Medicinal preparation containing phenylethanoid glycosides extracted from Cistanche tubulosa |
| 01/19/2005 | EP1498125A1 Use of compounds having ccr antagonism |
| 01/19/2005 | EP1498124A2 The use of inhibitors of the renin-angiotensin system |
| 01/19/2005 | EP1497330A2 Antagonists of factor viii interaction with low-density lipoprotein receptor-related protein |
| 01/19/2005 | EP1497283A1 Maleic acid salt of(2s)-n-(5(amino(imino)methyl)-2-thienyl)methyl-1-(2r)-2-((2r)-2-((carboxymethyl)amino)3,3-diphenylpropanoyl)-2-pyrrolidine carboxamide and a process for |
| 01/19/2005 | EP1497273A2 Hydroxamic acid derivatives |